Caris Life Sciences, Inc. Common Stock (CAI) earnings · rev $812.0M
These earnings events as JSON? API free 100/dayCaris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
This CAI earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
When the next CAI 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 97.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CAI research stays on the stock page; the tape stays on the quote page.
CAI earnings FAQ
What are CAI's latest revenue and net income?
Latest cached Caris Life Sciences, Inc. Common Stock (CAI) revenue for Dec 31, 2025 was $812.0M. Net income was -$68.1M. Statements: https://lician.com/financials/cai
What is CAI's latest diluted EPS?
Latest cached Caris Life Sciences, Inc. Common Stock (CAI) diluted EPS for Dec 31, 2025 was -$0.41.
What period does the latest CAI earnings print cover?
The latest cached Caris Life Sciences, Inc. Common Stock (CAI) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CAI revenue change from the prior cached period?
Cached Caris Life Sciences, Inc. Common Stock (CAI) revenue was up 97.0% from $412.3M (Dec 31, 2024) to $812.0M (Dec 31, 2025). Statements: https://lician.com/financials/cai
Where are CAI earnings listed?
Cached earnings facts for Caris Life Sciences, Inc. Common Stock (CAI) are listed at https://lician.com/earnings/cai. Statements: https://lician.com/financials/cai
Not investment advice.